T

TregTherapeutics Inc.

2 employees

TregTherapeutics is a preclinical stage company focused on the treatment and possible cure of multiple sclerosis.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Clinical Trials

Date founded

2018

Funding rounds raised

Total raised

$250K

from 1 investors over 1 rounds

T

TregTherapeutics Inc. raised $250K on January 1, 2019

Investors: North Carolina Biotechnology Center (NCBiotech)

FAQ